Skip to main content
Loading
7:00 AM
  1. Broadway Ballroom
    120 mins
    Our networking breakfast is for registered attendees only.
  2. 6th Floor Registration
    660 mins
    Attendees must come to registration to pick up their badge.
9:15 AM
  1. Uris
    15 mins
    Kernal Bio is a biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectively translated in cance ...
  2. Royale
    15 mins
    Antibodies have become the top-selling class of therapeutics stemming from their high level of specificity and affinity for disease proteins as well as their ability to target diverse molecules with a ...
  3. Plymouth
    15 mins
    Calissa Therapeutics is a clinical stage dermatology company targeting vascular lesions. Our lead indications are rosacea and port wine birthmark, one of the most common birthmarks. Lead asset CX-001 ...
  4. 165 mins
9:30 AM
  1. Plymouth
    15 mins
    Rejuvenation Technologies in developing therapeutics to extend telomeres to combat diseases of aging.
  2. Uris
    15 mins
    Clinical Efficacy in the Toughest Cancers -- Cracking the Code on Dendritic Cell Therapy and Tumor Infiltrating Lymphocytes Diakonos Oncology is developing two cell therapy technologies developed at M ...
  3. Royale
    15 mins
    Aileron is developing novel medicines to provide better treatment options for patients with life-threatening pulmonary conditions. With its acquisition of Lung Therapeutics, Aileron is shifting its di ...
9:45 AM
  1. Royale
    15 mins
    Vasomune Therapeutics Inc., is a clinical stage biopharma, with an asset in mid-phase 2a. AV-001, is a Tie-2 agonist that corrects vascular endothelial dysfunction and shows strong activity against li ...
  2. Plymouth
    15 mins
    Reversing osteoarthritis. Introducing an unprecedented category innovation in nanotechnology to fully restore the joint function in osteoarthritic patients, with impeccable results paving the way to c ...
10:00 AM
  1. Majestic Complex
    50 mins
    This session will begin with a presentation from the HSBC Innovation Banking 2023 annual report. The report shows investment pace similar to 2H 2022, with crossovers returning to lead later-stage deal ...
  2. Plymouth
    15 mins
    Saghmos Therapeutics is developing ST-62516 to reduce the risk of Acute Kidney Injury (AKI) and Major Adverse Cardiac and Kidney Events (MACKE) after contrast procedures such as percutaneous coronary ...
  3. Uris
    15 mins
    Processa Pharmaceuticals is a clinical stage pharmaceutical company developing Next Generation Chemotherapies (NGCs) to address the underlying challenges of current drugs by modifying pharmacokinetics ...
  4. Royale
    15 mins
    BioHarvest Sciences has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial plant-based compounds, at an industrial scale, without the need to gro ...
10:15 AM
  1. Plymouth
    15 mins
    Mercy BioAnalytics is a pre-commercial diagnostics company on a mission to save lives and relieve suffering through the early detection of cancer. We are developing ,broadly accessible, inexpensive, b ...
  2. Uris
    15 mins
    SciTech is a clinical-stage oncology-focused drug delivery technology company. Our initial clinical trial is underway with IRB-approved sites at UPMC, Columbia University, MD Anderson, USC, U Michigan ...
  3. Royale
    15 mins
    Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Humanetics entered the field of radiation modulators through a cooperative research ...
10:30 AM
  1. Uris
    15 mins
    Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to hel ...
  2. Plymouth
    15 mins
    A new brain liquid biopsy - Neuron Derived Exosomes, their use, and their promise in disease stratification.
  3. Royale
    15 mins
    ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with renal or inflammatory disea ...
10:45 AM
  1. Plymouth
    15 mins
    Seek Labs is developing next generation molecular diagnostics technologies that have the potential to revolutionize the detection and treatment of diseases. Point of care diagnostics is currently limi ...
  2. Royale
    15 mins
    Supernova Bio is a R&D-focused bio-venture that has developed therapeutic agents for lipolysis, anti-lipoma, and liposarcoma by utilizing gas-generating polymer nanoparticles that significantly reduce ...
  3. Uris
    15 mins
    Indaptus Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy ...
11:00 AM
  1. Majestic Complex
    50 mins
    More than 30 genetic medicine treatments have been approved by the FDA so far, with hundreds more in the clinical pipeline, but companies working in these newer modalities have been challenged by scal ...
  2. Uris
    15 mins
    Bexion Pharmaceuticals is a mid-clinical stage biotechnology company developing biologics for the treatment of solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN). Our lead asset ...
  3. Royale
    15 mins
    ZWI Therapeutics is a US biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s new proprietary polymer shows improved pharmacokinetics and reduced potent ...
  4. Plymouth
    15 mins
    EosDx is creating a new modality for AI-driven cancer detection using Bio-crystallography that identifies cancer biomarkers in tissue using a non-invasive, safe, accurate, and objective test
11:15 AM
  1. Uris
    15 mins
    Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and othe ...
  2. Royale
    15 mins
    Scenic Biotech is a biopharmaceutical company advancing modifier therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier th ...
  3. Plymouth
    15 mins
    GenEndeavor is a molecular diagnostics technology company on a mission to prevent genetic and infectious diseases by quickly and accurately detecting pathological biomarkers in early stages.
11:30 AM
  1. Uris
    15 mins
    Cytovation is a clinical-stage oncology biotech focused on the development of CyPep-1, a first-in-class synthetic peptide designed to drive a systemic anti-cancer immune response, with a unique dual m ...
  2. Plymouth
    15 mins
    Jan Biotech, Inc. has developed a disruptive RNA detection technology that provides unprecedented prediction accuracy (0.97) for time to rebound for antiretroviral treated HIV-infected individuals and ...
  3. Royale
    15 mins
    At this meeting, we will present "Losing Fat Mass without Impacting Muscle Mass: A New Approach for Weight Loss". Ridgeline is developing transformative oral drugs for the multi-billion obesity and mu ...
11:45 AM
  1. Plymouth
    15 mins
    BRINTER, a first-mover US medical technology firm with 3D bioprinted universal human cartilage platform (BioMods™) for the $10B+ cartilage repair market. Our first 510(k) Nose-BioMod™ product is estim ...
  2. Royale
    15 mins
    EVast Bio is a US-based, clinical-stage biotech born as a result of ground-breaking work at C4C (https://c4c.cl). EVast Bio is devoted to exploring the vast potential of small Extracellular Vesicles ( ...
  3. Uris
    15 mins
    Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill t ...
12:00 PM
  1. Broadway Ballroom
    60 mins
    Our networking lunch is for registered attendees only.
1:00 PM
  1. Plymouth
    15 mins
    Protalix is a commercial-stage biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based express ...
  2. Uris
    15 mins
    BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with curre ...
  3. Royale
    15 mins
    IN8bio, a clinical-stage biopharmaceutical company, focuses on gamma-delta T cell product candidates for solid and liquid tumors. These T cells, naturally differentiating between healthy and diseased ...
  4. 240 mins
1:15 PM
  1. Royale
    15 mins
    Cognigenics is a privately held pre-clinical neuro-engineering company pioneering the frontier of RNA based therapeutics and focused on developing and commercializing innovative genetic medicines to t ...
  2. Uris
    15 mins
    Tactical Therapeutics, Inc is a clinical stage private Co in New York, developing Carboxyamidotriazole orotate (CTO) which has shown safety and efficacy in primary brain cancer and many undruggable he ...
  3. Plymouth
    15 mins
    Sernova is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and hemophilia A. The Co ...
1:30 PM
  1. Uris
    15 mins
    Leapfrog Bio is a seed stage company focused on developing precision therapeutics targeting solid tumors caused by loss of function mutations. Since inception in 2019 the company has developed and val ...
  2. Plymouth
    15 mins
    Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fi ...
  3. Royale
    15 mins
    Tonix is a biopharmaceutical company commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is fo ...
1:45 PM
  1. Uris
    15 mins
    ImmuneOnco is a HongKong stock exchange-listed, clinical stage biotech company focused on discovering and developing immunotherapies to treat cancer. The most advanced clinical program is timdarpacept ...
  2. Plymouth
    15 mins
    Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the gl ...
  3. Royale
    15 mins
    Allyx Therapeutics was founded in 2019 by a group of seasoned biopharma industry executives, venture capitalists, and scientific experts. The company aims to deliver a novel approach to preserve and p ...
  4. Majestic Complex
    15 mins
    Join Andrew Kimball, NYCEDC President & CEO, to learn how LifeSci NYC, a $1 billion initiative of the New York City Economic Development Corporation (NYCEDC), is helping New York City become a world l ...
2:00 PM
  1. Majestic Complex
    50 mins
    Attend this session to learn about recent research from the BIO Industry Analysis team on the history and future of vaccine pipelines. A dynamic conversation on how to finance this space along with th ...
  2. Uris
    15 mins
    Carina Biotech is a clinical stage immuno-oncology company developing CAR-T and other adoptive cell therapies for the treatment of solid cancers. In addition to its LGR5-targeted CAR-T cell therapy CN ...
  3. Royale
    15 mins
    CervoMed is a clinical stage company targeting synaptic dysfunction to treat age-related neurologic disorders. The Company is currently developing neflamapimod, an oral small molecule brain penetrant ...
  4. Plymouth
    15 mins
    A Clinical-stage Biotech Company Developing ‘Off-the-shelf’ Non-gene Modified Hematopoietic Stem Cells & Its Derived Immune Cell Therapies For Cancer Patients.
2:15 PM
  1. Plymouth
    15 mins
    Immunis is a private biotechnology company researching and developing secretome products to address age-driven immune deficits. Immunis has developed a novel method to grow human cells for clinical us ...
  2. Royale
    15 mins
    Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra’s LYNX® drug delivery platform is one of the most significant advances in oral drug deli ...
  3. Uris
    15 mins
    At Avstera, our primary initial focus is to address the significant unmet need of advanced cancer patients who have limited or no treatment options. These include patients who fail to respond to exist ...
2:30 PM
  1. Uris
    15 mins
    Cyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics and mitosis biology. The transcriptional regu ...
  2. Plymouth
    15 mins
    SIRPant Immunotherapeutics, Inc., a clinical stage company, programs the cells that drive immunity – macrophages – to mobilize effective polyclonal anti-cancer immune responses, providing a novel mult ...
  3. Royale
    15 mins
    NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipola ...
2:45 PM
  1. Plymouth
    15 mins
    Pioneering marcrophage cell therapy to transform the outcomes of patients with End Stage Liver Disease
  2. Uris
    15 mins
    Chimeric Therapeutics, is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. Chimeric is developing two first in class autolog ...
  3. Royale
    15 mins
    Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, ...
3:00 PM
  1. Majestic Complex
    50 mins
    A recent IQVIA Institute report forecasts that spending on cancer medicines is expected to reach $375Bn globally by 2027, up from $196Bn in 2022. As companies seek to bring these therapies to market a ...
  2. Royale
    15 mins
    Ziphius is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform to all ...
  3. Uris
    15 mins
    tbc
3:15 PM
  1. Royale
    15 mins
    SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing fully-human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalesc ...
  2. Uris
    15 mins
    Celebrating its 20th anniversary, Genesis Healthcare is Japan’s leading genetic testing and research company, servicing medical institutions, government, corporations, and individuals to benefit from ...
  3. Plymouth
    15 mins
    Coastar Therapeutics is a venture-backed biotech company based in San Diego, CA, focused on next generation gene delivery technology. The company has developed a novel ENHEnS application that can coat ...
3:30 PM
  1. Royale
    15 mins
    Inimmune is a private clinical stage company dedicated to developing immuno-therapeutics. It is focused on advancing its Toll Like Receptor ligand portfolio as immunotherapeutics and vaccine adjuvants ...
  2. Plymouth
    15 mins
    Papillon Therapeutics is advancing gene therapy treatments for life threatening conditions with neurologic disease, including Friedreich's ataxia, Danon disease, and Alzheimer’s disease. We specialize ...
  3. Uris
    15 mins
    Vincogen corporation (www.vincogen.com) is the Biotechnology - Artificial Intelligence company and has developed VincoAI, a collection of generative AI models. VincoAI is the first proof-of-concept ge ...
3:45 PM
  1. Uris
    15 mins
    Portal Instruments is a clinical-stage drug delivery and digital health company transforming injectable biologics into 21st century therapies that are needle-free and seamlessly cloud-connected. Porta ...
  2. Plymouth
    15 mins
    Garuda’s mission is to bring curative blood stem cell therapy to patients worldwide suffering from serious diseases, while eliminating the dependency on donor or patient cells for transplants. Garuda’ ...
4:00 PM
  1. Majestic Complex
    50 mins
    With biotechnology stock indexes down nearly ten percent and little IPO appetite, companies’ access to fresh capital is particularly constrained, creating opportunities and challenges for those fortun ...
  2. Uris
    15 mins
    Sapience Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing peptide therapeutics to address oncogenic and immune dysregulation that driv ...
  3. Plymouth
    15 mins
    EG 427 develops a unique vector platform to deliver pinpoint neurotherapeutics to treat prevalent diseases of the peripheral and central nervous system. Our vectors can achieve focal transduction in s ...
  4. Royale
    15 mins
    Diamyd Medical is a Stockholm-based, precision medicine company developing an antigen-specific immunotherapy for the treatment and prevention of (autoimmune) Type 1 Diabetes in a genetically defined r ...
4:15 PM
  1. Royale
    15 mins
    GeoVax is developing novel therapies and vaccines for solid tumor cancers and infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedept ...
  2. Uris
    15 mins
    Alligator Bioscience is a clinical-stage biotech company developing agonistic antibody-based pharmaceuticals for tumour-directed immunotherapy of cancer. Our lead asset, mitazalimab, a second generati ...
  3. Plymouth
    15 mins
    Navega Therapeutics' mission is to develop durable relief for chronic and complex diseases, via DNA gene regulation. The company’s technology is centered around a ZF-AI, a proprietary deep learning al ...
4:30 PM
  1. Royale
    15 mins
    Uvax Bio is a clinical stage, privately funded biotechnology company focused on developing vaccines to address unmet clinical needs in the prevention of infectious diseases. Uvax Bio holds the exclusi ...
  2. Plymouth
    15 mins
    Sustained Therapeutics is a clinical stage company utilizing advanced clinical and research expertise to develop a patented novel locally injected sustained-release drug delivery platform. This platfo ...
  3. Uris
    15 mins
    Innova Therapeutics is a Charleston, South Carolina based biotechnology company developing a monoclonal antibody (mAb) platform targeting a protein, secreted frizzled related protein 2 (SFFRP2), that ...
4:45 PM
  1. Uris
    15 mins
    MERLIN Biotech is a pre-clinical stage mRNA platform company with a novel 1st in class cancer immunotherapy with exclusive IP in major worldwide markets. Our target, USP6, has demonstrated invivo effi ...
  2. Royale
    15 mins
    Gentas' mission is to bridge BioPharma’s translational gap by providing preclinical testing services using miniature swine models. Gentas will dramatically improve the success rate for testing by 1) i ...
  3. Plymouth
    15 mins
    Nanoscope Therapeutics is a clinical-stage biopharmaceutical company developing gene therapies to cure genetic diseases that cause vision impairment and blindness.
5:00 PM
  1. 60 mins
    This is an invite-only event. The reception will take place immediately prior to the Monday Night Welcome Reception and will provide an opportunity to network with other BIO members. You’ll also be ab ...
6:00 PM
  1. 9th Floor Upper Terrace
    60 mins
    Welcome Reception on the 9th Floor Upper Terrace
6:30 AM
  1. Broadway Ballroom
    150 mins
    Our networking breakfast is for registered attendees only.
  2. 6th Floor Registration
    630 mins
    Attendees must come to registration to pick up their badge.
9:00 AM
  1. Majestic Complex
    50 mins
    As Congressional and Presidential elections approach, pricing and access to medicines are topics of great interest and debate to different constituencies. Attend this conversation among dynamic stakeh ...
  2. Uris
    15 mins
    Predictive Oncology is a science-driven company leveraging its proprietary artificial intelligence (AI) and machine learning capabilities, a proprietary, extensive biorepository of tumor samples, Clin ...
  3. Plymouth
    15 mins
    AyuVis is pioneering novel small molecule immunotherapies to prevent/treat inflammatory and infectious diseases based on a platform technology of macrophage modulation for a balanced immune response. ...
  4. 180 mins
9:15 AM
  1. Plymouth
    15 mins
    Caledon Biosciences is a privately held, start-up founded in October 2023. Caledon owns the key assets, management and operations of a former NASDAQ listed entity, Liminal BioSciences Inc, which was r ...
  2. Uris
    15 mins
    AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. We take a unique pan-antigenic approach for our cancer v ...
9:30 AM
  1. Plymouth
    15 mins
    Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by adv ...
  2. Uris
    15 mins
    Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been sh ...
9:45 AM
  1. Uris
    15 mins
    Citius Pharma is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunc ...
10:00 AM
  1. Majestic Complex
    50 mins
    Many patient advocates focus on the development and approval of new medicines. Investors typically learn about the pathway to approval via the companies that develop the therapies. However, the opport ...
  2. Uris
    15 mins
    Actithera is an early-stage radiotherapeutics company with a platform for the design of Theranostics with prolonged tumor retention and rapid peripheral clearance. Its approaches have been validated i ...
  3. Plymouth
    15 mins
    Neurocentrx is seeking the 1st FDA approval of an abuse-deterrent oral ketamine therapy for depression suitable for clinical and home administration. The company is Phase 3 ready, with a patent abuse- ...
10:15 AM
  1. Uris
    15 mins
    Panavance Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company developing a novel oncology asset, misetionamide (known as GP-2250). Panavance was formed in 2021 as a carve out ...
  2. Plymouth
    15 mins
    Bionomics, a publicly listed clinical late-stage company focused on addressing unmet needs in CNS. We are developing BNC-210, a Ph3-Ready First- and-Best-in-Class α-7 Nicotinic Receptor for the Treatm ...
10:30 AM
  1. Plymouth
    15 mins
    Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The Company is head ...
  2. Uris
    15 mins
    Starton is a clinical-stage biotechnology company transforming standard of care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to liv ...
10:45 AM
  1. Plymouth
    15 mins
    Elsie Bio is focused on applying medicinal chemistry to oligonucleotide development. We use DNA encoded technology to design and develop optimal RNA therapeutics. Our approach is redefining how we tre ...
  2. Uris
    15 mins
    Oncoteq is a clinical stage oncology biotech with a focus on first or best-in-class treatments in areas of high unmet need. The company portfolio comprises two highly differentiated assets. TEQ103 has ...
11:00 AM
  1. Uris
    15 mins
    ZTI BIOSCIENCES specializes in the development of radiopharmaceuticals for cancer therapeutics based on the Nano-tech platform (TERACARRIER™), distinguished as the world's first and only technology. [ ...
  2. Majestic Complex
    30 mins
  3. Plymouth
    15 mins
    ProMIS Neurosciences (Nasdaq:PMN) is a Cambridge, Massachusetts and Toronto, Ontario-based clinical stage biotechnology company committed to the discovery and development of therapeutic antibodies sel ...
11:15 AM
  1. Plymouth
    15 mins
    Editpep produces CRISPR based therapeutics by leveraging the Transporter peptide based delivery platform, focusing on CNS and eye indications.
  2. Uris
    15 mins
    Larkspur Biosciences is pioneering a new wave of cancer therapy by developing medicines that target immune evasion where it starts – in the cancer. Our integrated discovery and translational approach ...
11:30 AM
  1. Uris
    15 mins
    Luminary stands out as a clinical stage CAR-T therapy company utilizing a unique allogeneic manufacturing platform. Our CAR and TCR development revolve around gamma delta cells, giving our allogeneic ...
  2. Plymouth
    15 mins
    Finding new therapies for brain diseases requires preclinical models and assays with increased clinical relevance. a:head aims to develop a human-based platform for generating complex brain-like tissu ...
11:45 AM
  1. Plymouth
    15 mins
    Ashvattha is a clinical stage company with a transformative nanomedicine technology exclusively licensed from Johns Hopkins University. The nanomedicine, hydroxyl dendrimers (HDs), precisely targets r ...
  2. Uris
    15 mins
    Apricity Health is a precision oncology company at the intersection of digital health, AI and biotechnology. It pioneers Dynamic Precision™, which mines longitudinal clinical and molecular data from p ...
12:00 PM
  1. Broadway Ballroom
    60 mins
    Our networking lunch is for registered attendees only.
1:00 PM
  1. Majestic Complex
    50 mins
    OpenAI’s ChatGPT exploded onto the scene in November 2022, attracting 1 million users in 5 days, and now more than 1.5 billion visits per month. It joins the class of AI tools including several used i ...
  2. Plymouth
    15 mins
    PTM Therapeutics is a pre-clinical stage antibody therapeutics company developing therapies through targeting post-translational modifications for the treatment of inflammatory bowel disease and solid ...
  3. 240 mins
1:15 PM
  1. Plymouth
    15 mins
    First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company is currently adva ...
1:30 PM
  1. Plymouth
    15 mins
    Jaguar Health is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals ...
  2. Uris
    15 mins
    Reglagene is revolutionizing brain disease therapy by targeting tubulin with a groundbreaking class of selective inhibitors. Our novel compounds, led by RGN6024, offer a blend of oral administration, ...
1:45 PM
  1. Uris
    15 mins
    Satellite Bio is a well-funded regenerative medicine company with cutting-edge hepatocyte technologies designed to tackle a broad range of liver diseases. Our platform encompasses a proprietary primar ...
  2. Plymouth
    15 mins
    Kanglin Biotechnology (Hangzhou) Co., Ltd. was founded in 2015 with the goal of translating advances in genetic science into curative treatments for previously incurable diseases. We believe in the gr ...
2:00 PM
  1. Majestic Complex
    50 mins
    The first generation of GLP-1 receptor agonists have shown themselves to be blockbuster breakthroughs for the management of diabetes with significant treatment benefits for obesity, an even more preva ...
  2. Uris
    15 mins
    SeraGene Therapeutics is a pre-clinical stage company using RNA and nanomedicine technology to provide long lasting, targeted control for coagulation disorders. Leveraging a deep understanding of clot ...
  3. Plymouth
    15 mins
    Alphyn is developing first-in-class Multi-Target Therapeutics® for severe and prevalent skin diseases based on its AB-101 platform, which has multiple bioactive compounds and, therefore, multiple mech ...
2:15 PM
  1. Plymouth
    15 mins
    IVIEW Therapeutics Inc. is a clinical-stage ophthalmology-focused therapeutics company based in Cranbury, New Jersey committed to the treatment of ocular diseases with high unmet medical needs through ...
  2. Uris
    15 mins
    Concerto Biosciences creates breakthrough microbe-based products originating from our unmatched understanding of microbial ecology. Microbes in, on, and around us work in concert to improve human heal ...
2:30 PM
  1. Plymouth
    15 mins
    ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with retinal disease. By advancing a breakthrough technology designed ...
  2. Uris
    15 mins
    At Intrepid Labs, we're pioneering the future of drug development through advanced AI, robotics, and drug formulation science. Our mission is to enhance patient care by making treatments more personal ...
2:45 PM
  1. Plymouth
    15 mins
    Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
3:00 PM
  1. Plymouth
    15 mins
    Epion Therapeutics is developing a minimally invasive treatment for keratoconus that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformative cross-link ...
  2. Majestic Complex
    50 mins
    Biotechnology IPO activity since the 2021 peak is still down more than 70%, tracking with the U.S. Federal Reserve’s lifting of interest rates. As macroeconomic forecasts envision interest rates to st ...
  3. Uris
    15 mins
    Nobias Therapeutics is a biotechnology company pioneering deep phenotyping to discover advanced therapeutics. Nobias uses its cutting-edge, applied AI platform to distill disease drivers and optimal p ...
3:15 PM
  1. Uris
    15 mins
    Biograil is developing the proprietary technology BIONDD(TM) capsule delivering biologic drugs with a bioavailability like SC injection creating a broad platform for oral delivery of drugs that would ...
3:30 PM
  1. Uris
    15 mins
    VerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
3:45 PM
  1. Uris
    15 mins
    Likarda has pioneered a groundbreaking platform for hydrogel delivery systems, offering both long- and short-term solutions that can either provide complete immuno-protection or degrade gradually. Thi ...
4:00 PM
  1. Uris
    15 mins
    CyGenica, a pioneering biotech startup, revolutionises intracellular therapeutics development through their drug delivery platform, GEENIE, which promises to redefine the landscape of pharmaceutical t ...
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP